0001493152-24-038572.txt : 20240927
0001493152-24-038572.hdr.sgml : 20240927
20240927170013
ACCESSION NUMBER: 0001493152-24-038572
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240927
DATE AS OF CHANGE: 20240927
EFFECTIVENESS DATE: 20240927
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dermata Therapeutics, Inc.
CENTRAL INDEX KEY: 0001853816
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-525299
FILM NUMBER: 241335786
BUSINESS ADDRESS:
STREET 1: 3525 DEL MAR HEIGHTS RD., #322
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858)-223-0882
MAIL ADDRESS:
STREET 1: 3525 DEL MAR HEIGHTS RD., #322
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
D
1
primary_doc.xml
X0708
D
LIVE
0001853816
Dermata Therapeutics, Inc.
3525 DEL MAR HEIGHTS RD., #322
SAN DIEGO
CA
CALIFORNIA
92130
(858) 800-2543
DELAWARE
None
None
Corporation
true
2021
Gerald
Proehl
3525 DEL MAR HEIGHTS RD., #322
San Diego
CA
CALIFORNIA
92130
Executive Officer
Director
Kyri
K.
Van Hoose
3525 DEL MAR HEIGHTS RD., #322
San Diego
CA
CALIFORNIA
92130
Executive Officer
Christopher
J.
Nardo
3525 DEL MAR HEIGHTS RD., #322
San Diego
CA
CALIFORNIA
92130
Executive Officer
Maria
Bedoya Toro Munera
3525 DEL MAR HEIGHTS RD., #322
San Diego
CA
CALIFORNIA
92130
Executive Officer
David
Hale
3525 DEL MAR HEIGHTS RD., #322
San Diego
CA
CALIFORNIA
92130
Director
Wendell
Wierenga
3525 DEL MAR HEIGHTS RD., #322
San Diego
CA
CALIFORNIA
92130
Director
Andrew
Sandler
3525 DEL MAR HEIGHTS RD., #322
San Diego
CA
CALIFORNIA
92130
Director
Brittany
Bradrick
3525 DEL MAR HEIGHTS RD., #322
San Diego
CA
CALIFORNIA
92130
Director
Kathleen
Scott
3525 DEL MAR HEIGHTS RD., #322
San Diego
CA
CALIFORNIA
92130
Director
Mary
Fisher
3525 DEL MAR HEIGHTS RD., #322
San Diego
CA
CALIFORNIA
92130
Director
Steven
J.
Mento
3525 DEL MAR HEIGHTS RD., #322
San Diego
CA
CALIFORNIA
92130
Director
Other Technology
Decline to Disclose
- 06b
false
2024-09-17
false
true
true
false
0
H.C. Wainwright & Co., LLC
000000375
None
None
430 PARK AVENUE
4TH FLOOR
New York
NY
NEW YORK
10022
All States
false
3498089
3498089
0
false
1
345000
true
0
Includes a cash fee received of $245,000, $35,000 (management fees), $25,000 (non-accountable expense), $40,000 (legal) and warrants to purchase 133,880 shares of common stock.
0
true
Some of the proceeds may be used for working capital and general corporate purposes, including the payment of salaries and other fees to those listed in Item 3.
false
Dermata Therapeutics, Inc.
/s/ Gerald Proehl
Gerald Proehl
Chief Executive Office
2024-09-27